Splenectomy for HIV-related immune thrombocytopenia: Comparison with results of splenectomy for non-HIV immune thrombocytopenic purpura

Archives of Surgery

Volumn 133, Issue 2, 1998, Pages 205-210

  Lord, Reginald V N ^a   Coleman, Maxwell J ^a   Milliken, Samuel T ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DANAZOL; IMMUNOGLOBULIN; VINCRISTINE SULFATE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; RISK FACTOR; SPLEEN WEIGHT; SPLENECTOMY; STREPTOCOCCUS INFECTION; THROMBOCYTE COUNT; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0031939848     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.2.205     Document Type: Article

References (40)

1. Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982;96:714-717.
2. Tyler DS, Shaunak S, Bartlett JA, Iglehart JD. HIV-1-associated thrombocytopenia: the role of splenectomy. Ann Surg. 1990;211:211-217.
3. Galli M, Musicco M, Gervasoni C, et al. No evidence of a higher risk of progression to aids in patients with HIV-1-related severe thrombocytopenia. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:268-275.
4. Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematology. 1992;48:168-172.
5. Rossi G, Gorla R, Stellini R, et al. Prevalence, clinical and laboratory features of thrombocytopenia among HIV-infected individuals. AIDS Res Hum Retroviruses. 1990;6:261-269.
6. Mientjes GH, van Ameijden EJ, Mulder JW, van den Hoek JA, Coutinho RAV, dem Borne AE. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men. Br J Haematology. 1992;82:615-619.
7. Walsh C, Krigel R, Lenette E, Karpatkin S. Thrombocytopenia in homosexual patients: prognosis, response to therapy, and prevalence of antibody to the retro-virus associated with the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103:542-545.
8. Stasi R, Stipa E, Masi M, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436-442.
9. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
10. Barbui T, Cortelazzo S, Minetti B, Galli M, Buelli M. Does splenectomy enhance risk of AIDS in HIV-positive patients with chronic thrombocytopenia? Lancet. 1987;2:342-343.
11. Schneider PA, Abrams DI, Rayner AA, Hohn DC. Immunodeficiency-associated thrombocytopenic purpura (IDTP): response to splenectomy. Arch Surg. 1987;122:1175-1178.
12. Ferguson CM. Splenectomy for immune thrombocytopenia related to human immunodeficiency virus. Surg Gynecol Obstet. 1988;167:300-302.
13. Ravikumar TS, Allen JD, Bothe A Jr, Steele G Jr. Splenectomy: the treatment of choice for human immunodeficiency virus-related immune thrombocytopenia? Arch Surg. 1989;124:625-628.
14. Landonio G, Nosari A, De Cataldo F. More on splenectomy for severe HIV-related thrombocytopenia. AIDS. 1990;4:1304.
15. Oksenhendler E, Bierling P, Chevret S, et al. Splenectomy is safe and effective in-human immunodeficiency virus-related immune thrombocytopenia. Blood. 1993;82:29-32.
16. Alonso M, Gossot D, Bourstyn E. Splenectomy in human immunodeficiency virus-related thrombocytopenia. Br J Surgery. 1993;80:330-333.
17. Kemeny MM, Cooke V, Melester TS, et al. Splenectomy in patients with AIDS and AIDS-related complex. AIDS. 1993;7:1063-1067.
18. Stricker R, Abrams D, Corash L, Shuman M. Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med. 1985;313:1375-1380.
19. Nieuwenhuis HK, Sixma JJ. Thrombocytopenia and the neglected megakaryocyte. N Engl J Med. 1992;327:1812-1813.
20. Walsh CM, Nardi MA, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med. 1984;311:635-639.
21. Dominguez A, Gamallo G, Garcia R, Lopez-Pastor A, Pena JM, Vazquez JJ. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol. 1994;47:999-1003.
22. Najean Y, Rain JD. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med. 1994;123:415-420.
23. Sehr T, Bair HJ, Becker W, Wolf F, Schwab J. Aetiology of HIV-associated thrombocytopenia. Lancet. 1994;343:479.
24. Zauli G, Catani L, Gibellini D, et al. Impaired survival of bone marrow GPIIB/IIIA (+) megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br J Haematology. 1996;92:711-717.
25. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus imfection. N Engl J Med. 1992;327:1779-1784.
26. Landonio G, Nosari A, Spinelli F. HIV-related thrombocytopenia. N Engl J Med. 1993;328:1785.
27. Zucker-Franklin D, Cao YZ. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci U S A. 1989;86:5595-5599.
28. Louache F, Bettaieb A, Henri A, et al. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood. 1991;78:1697-1705.
29. Li Y, Gold J, McDonald AM, Kaldor JM. Demographic pattern of AIDS in Australia, 1991 to 1993: the National HIV Surveillance Committee. Aust N Z J Public Health. 1996;20:421-425.
30. Australian HIV Surveillance Report. Sydney, Australia: National Centre in HIV Epidemiology and Clinical Research; 1995;11(1).
31. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
32. Lord RVN. Anorectal surgery in patients infected with human immunodeficiency virus: factors associated with delayed wound healing. Ann Surg. 1997;226:92-99.
33. Morlat P, Dequaemerchadou L, Dabis F, Chene G, Salamon R, Beylot J. Splenectomy and prognosis of HIV infection. AIDS. 1996;10:1170-1172.
34. Genet P, Lionnet F, Pulik M, Petitdidier C, Le Turdu F. Severe pneumococcal infections in splenectomized HIV-positive patients. AIDS. 1994;8:850-851.
35. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992;117:314-324.
36. Greub G, Erard P, Von Overbeck J. HIV infection and splenectomy: 3 cases and review of the literature. Schweiz Med Wochenschr. 1996;126:1524-1529.
37. Corazza GR, Zoli G, Ginaldi L, et al. Tuftsin deficiency in AIDS. Lancet. 1991;337:12-13.
38. Ballet JJ, Sulcebe G, Couderc LJ, et al. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol. 1987;68:479-487.
39. Huang LL, Ruben FL, Rinaldo CK Jr, Kingsley L, Lyter DW, Ho M. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA. 1987;257:2047-2050.
40. Centers for Disease Control Disease and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993;42 (RR-4):1-18.